






































































































A narrative review on endopancreatic
interventions: an innovative access to the
pancreas
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Abstract
The natural connection between the duodenum and the pancreatic duct enables a minimally invasive access to the pancreas.
Endoscopically this access is already regularly used, mainly for diagnostic and even for certain therapeutic purposes. With per-oral
pancreatoscopy the endopancreatic approach allows the direct visualization of the pancreatic duct system potentially improving the
diagnostic work-up of pancreatic cystic neoplasms, intrapancreatic strictures and removal of pancreatic duct stones. However, the
endopancreatic access can equally be applied for surgical interventions. The objective of this review is to summarize endoscopic and
surgical interventions using the endopancreatic access. Endopancreatic surgery stands for a further development of the endoscopic
technique: a rigid endoscope is transabdominally introduced over the duodenum and the papilla to enable resections of strictures
and inflamed tissue from inside the pancreas under visual control. While the orientation and localization of target structures using this
minimally invasive approach is difficult, the development of an accurate image guidance system will play a key role for the clinical
implementation and widespread use of endoscopic and surgical endopancreatic interventions.
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Introduction
Visualization of the pancreaticobiliary system is challenging and
evaluation mainly relies on radiographic techniques such as
computed tomography (CT), magnetic resonance imaging (MRI)
and endoscopic ultrasound (EUS). However, the natural connec-
tion between the duodenum and the pancreatic duct enables both
diagnostic and therapeutic interventions. Foremost, endoscopic
retrograde cholangiopancreatography uses this connection for
diagnostic and therapeutic options. For example, endoscopic
retrograde cholangiopancreatography enables pancreatic duct
stone extraction and has a success rate of around 50%.[1–5]
Potential improvement could be brought through direct visualiza-
tion of the pancreatic duct with subsequent intervention through
the duct, as made possible by per-oral pancreatoscopy (POP). POP
was first described in 1976 by Kawai et al.[6] It is clinical
implementation was initially limited by several problems such as
the need for two endoscopists, the fragility of the instruments and
poor image quality. In 2007 a single operator, fiberoptic scope
system was introduced, which enabled execution of the procedure
by a single endoscopist but still had the limitation of poor image
quality and instability.[7,8] In 2015 a digital cholangio-pancreato-
scope overcoming these issues was introduced (SpyGlass DS,
Boston Scientific).[9] POP is useful for the visualization and
histological diagnosis of intraductal papillarymucinous neoplasms
(IPMN). Furthermore, POP can be helpful in the challenging
differentiation between benign and malignant pancreatic duct
strictures. POP enables direct interventions, such as the removal of
pancreatic duct stones by pancreatoscopy guided lithotripsy.[10]
Recently, more advanced intraductal techniques have gained
interest, for example, in the form of intraductal radiofrequency
ablation (RFA).[11] The natural connection between duodenum
and pancreatic duct was furthermore evaluated as a minimally
invasive surgical access to the pancreas, the so called endopancre-
atic surgery (EPS).[12–15] This technique is using a rigid endoscope
enabling stable access and the use of rigid resection instruments.[12]
Endopancreatic procedures—either performedvia per-oralflexible
endoscope or surgically with rigid instruments present a fascinat-
ingandquickly evolvingfield, therefore,weaimed topresent anup-
to date review of recent developments and outcomes using the
endopancreatic access.
Database search strategy
We searched PubMed to find articles on endopancreatic
interventions that were published between 2000 and 2021.
Endoscopic interventions
POP
POP has the advantage of direct visibility of the pancreatic duct
system with the possibility to perform diagnostic and therapeutic
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interventions. Technical progress resolved initial issues of the
technique like poor image resolution and complicated and fragile
handling. Compared to endoscopic retrograde cholangiopan-
creatography, POP offers advanced endoscopic treatment
options for pancreatolithiasis with the combination of endoscopy
and lithotripsy in one device. Through the POP working channel
it is possible to perform intraductal laser lithotripsy. A success
rate between 38% and 100%[16] has been shown for POP
lithotripsy compared to 59% to 76% with extracorporeal shock
wave lithotripsy.[17] Attwell et al used dual operator-based (n=
31) and single operator-based (n=15) pancreatoscopes. Com-
plete clearance was achieved in 68% for dual operator-based
POP and 73% for single operator-based POP. Clinical success
was defined as >50% reduction in opiate use, pain or
hospitalization and was achieved in 74%. Of note, 10% had
POP-related complications.[18] In general POP-guided laser
lithotripsy leads to a pancreatic duct clearance between 79%
and 85%.[19,20] Moreover, POP adds valuable diagnostic
information, especially in the challenging diagnostic of mucin-
producing tumors of the pancreas (MPTP). Particularly main
duct IPMN have an increased risk for malignant transforma-
tion[21] and the differentiation between low and high risk IPMN
remains challenging.[22] According to the POP visualization the
cystic lesions can be divided into 5 groups (Fig. 1) according to
the different potential of malignant transformation.[23] In groups
3 to 5, where over 89% of the cystic lesions were malignant, POP
had a sensitivity of 68% and a specificity of 87% detecting
malignancy. When using POP additional diagnostic information
affecting clinical decision-making was found in 76% of the
patients by Arnelo et al. The sensitivity was 84% and the
specificity 75% for identifying malignant lesions.[24] With three
passes of either POP-guided biopsy, POP-assisted fluoroscopic-
guided biopsy or POP-guided brushing, El Hajj et al reached high
sensitivity and specificity for the detection of pancreatic duct
neoplasia (PDAC or main duct IPMN). In a cohort of 33 patients
the diagnosis was confirmed in 88% of the cases with POP-
guided tissue sampling. The sensitivity and specificity of the visual
diagnosis with POP was 87% and 86%, compared to 91% and
95% for POP with tissue sampling.[25] To visualize lesions in
distant branches a very useful addition to POP is intraductal
ultrasound (IDUS). Mukai et al found that the sensitivity for
detecting lesions ≥3mm was significantly higher for IDUS
(100%) compared to other diagnostic modalities (CT 21%, EUS
86%, POP 83%).[26] Adding IDUS to POP is especially beneficial
in the evaluation of branch duct lesions, where the accuracy of
differentiating benign and malignant lesions increased from 67%
with POP alone to 88% for POPwith IDUS.[23] Preoperative POP
adds valuable information for preoperative surgical planning.
According to Tyberg et al preoperative POP changed the surgical
plan in 62%, with a very high correlation (88%) between POP
and final histology.[27] If used intraoperatively POP can be of use
to detect lesions which were missed in the preoperative work-up.
In a prospective study Kaneko et al found intraductal MPTP in
ten out of 24 patients which were missed by preoperative imaging
and EUS. The sensitivity, specificity and accuracy of intraoper-
ative POP for diagnosis of MPTP was 100%.[28] POP adds
valuable information for the evaluation of cystic lesions of the
pancreas and may as well be beneficial in the assessment of
pancreatic duct strictures, especially in patients with chronic
pancreatitis (CP).
Intraductal ablation
Intraductal RFA is mainly applied in the biliary duct system for
the palliative management of malignant biliary strictures, in case
of stent occlusion or for the treatment of ampullary neo-
plasms.[11] Overall, RFA applied in the biliary system showed
promising results regarding stent patency and survival.[29–33] Due
to the sensitive nature of the pancreas parenchyma and the
delicate surrounding structures thermal ablation is only applied
in highly selected cases, mainly in patients who are unfit for
surgery.More recently EUS-guided RFA of pancreatic tumors has
gained interest.[34,35] Since this approach does not use the natural
connection between the duodenum and pancreas, EUS-guided
RFA is outside the scope of this review. Nevertheless, studies
which assessed efficacy and safety of RFA for the treatment of
residual intraductal lesions after endoscopic papillectomy have
been conducted.[36] Camus et al found a 70% chance for
dysplasia eradication at 12months after a single session of
intraductal RFA in patients which had residual neoplasia after
papillectomy.[37] Rustagi et al found a treatment success of 92%
for patients with intraductal extension (common bile duct or
pancreatic duct) of ampullary neoplasms treated with RFA.
However, adverse events are common and occurred in 43%,
especially mild pancreatitis or ductal strictures.[38] Although
these smaller studies showed the feasibility of intraductal RFA,
future studies have to clarify the actual benefit of this treatment.
Furthermore, the RFA devices are still undergoing a technical
development. Choi et al addressed the problem of adverse events
caused by heat with a temperature-controlled probe. The study
population was small, with 10 patients, but the treatment was
successful in 90% of the cases, with adverse events in 30%.[36]
Figure 1. Distribution of 51 protruding lesions by histopathological diagnosis and POPS (adapted with permission fromHara et al[23]). The cystic lesions are divided
into 5 types according to the POPS visualization. CIS=carcinoma in-situ, POPS=per-oral pancreatoscopy.
Frey et al Journal of Pancreatology (2021) 4:2 www.jpancreatology.com
91
Intraductal RFA was furthermore applied for the treatment of
IPMN in an 82-year-old man who was unfit for surgery. The
treatment with RFA was successful and there were no signs of
residual disease after 3months follow-up.[39] Adverse events after
RFA are still common,[40] besides the thermal damage, the
challenging navigation could be another key point to reduce
adverse events. The advancement of computer assisted image-
guided interventions or direct visualization of POP will facilitate
the targeting of intraparenchymal lesions. Interestingly, RFA
recently attracted interest for pancreatic stump closure after
surgery.[41,42] In a porcine model intraductal sealing of the
pancreatic duct was feasible in all animals without complications
(Fig. 2). After 30days, successful occlusion of the pancreatic duct
was confirmed in all cases.[42] Although only applied in very
selected indications, intraductal RFA has shown potential in
treatment of residual ampullary adenomas, sealing of the
pancreatic duct and might even be applied in highly selected
patients with IPMN unfit or unwilling to undergo surgery.
However, studies comparing intraductal RFA to current standard
treatment are required to reassure the benefit of this technique.
Surgical interventions
Endopancreatic surgery
EPS stands for a newly developed minimally invasive surgical
technique. The concept is similar to the transurethral resection of
the prostate. After laparoscopic access to the duodenum and the
papilla, diagnostic and therapeutic procedures (especially
resections) can be performed from inside the pancreatic duct
with a rigid endoscope under visual control (Fig. 3). The use of
rigid instruments compared to a flexible endoscope in this
sensitive organ brings several advantages like stability when
performing interventions, the option for various treatments
through the working channel and potentially a shorter learning-
curve.[43] As previously mentioned, endoscopic treatment in CP
has limitations, as it is impossible to resect the inflamed
pancreatic tissue, which is responsible for the progression of
the disease. While the surgical treatment has been shown to be
more effective,[44,45] the duodenum-preserving pancreatic head
resection and other procedures are associated with relevant
morbidity.[46] Minimally invasive procedures such as EPS could
potentially lower the morbidity while a resection of inflamed
tissue is possible from inside the organ.[47] First animal
experiments showed promising results and the feasibility of a
similar resection with EPS as with a duodenum-preserving
pancreatic head resection (Fig. 4).[12] The resected area accounted
for 30% of the total pancreatic surface with a resected volume of
14.2cm3. Furthermore, the often-present pancreatic duct stenosis
can be resected by EPS as well, as shown in a bovine pancreas
model with artificial pancreatic duct strictures. In 8 specimens all
stenoses could be resected and the stenotic area could then be
passed with the 2.7mm rigid endoscope. There were no
complications, especially no organ perforations. EPS is per-
formed with a rigid endoscope and a single working channel,
therefore this technique needs effective instruments for the
resection and especially for hemostasis. Both a conventional
monopolar electrosurgical device (MES) and a green light laser
(GLL) have been evaluated for EPS. Standardized resections were
performed in an in vivo porcine model (Supplementary Table 1,
http://links.lww.com/JP9/A9). Blood loss was less pronounced
withGLL thanwithMES [1.7 (0.6–2.6) mL vs 5.1 (3.8–13.2) mL;
P< .01], while there was no uncontrollable bleeding with either
technique. GLL also showed a shorter median procedure time
than MES [109 (81–127) seconds vs 390 (337–555) seconds;
P< .01]. However in the histopathological workup, GLL
was associated with more pronounced heat-damage than MES
Figure 2. In a porcine experiment the radiofrequency probe was inserted transpapillary and used to prevent leakage of the pancreatic duct (adapted with
permission from Andaluz et al[41]). B=bridge, CL=connecting lobe, DL=duodenal lobe, SL=splenic lobe.
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[4.12mm (3.48–4.89) vs 1.33mm (1.09–1.48); P< .01],[13]
which could potentially lead to fatal complications in the
postoperative course, such as postoperative pancreatitis or organ
perforations. However, the study was limited to an in-vivo
experiment without survival of the animals. One of the main
limitations of resections performed by EPS is the limited
orientation in the small pancreatic duct that relies on visual
feedback only. Unsurprisingly, two pancreatic perforations
occurred in the animal models because of difficulties in the
identificationof the organmargins.[12] Toovercome this difficulty,
image-guidance with a computer assisted navigation system was
proposed in an experimental model. The CT scan of a 3D
reconstruction of a silicon pancreas model was therefore
transferred to the CAS-One navigation system (CAScination
AG, Bern, Switzerland).[48,49] To fuse the virtual with the real
world, two techniques were evaluated. First, registration with
distinctive surface landmarks (LM) and second registration with
intraparenchymal LM was proposed. Different combinations of
these techniques were evaluated (1. surface LM only, 2. surface +
intraparenchymal LM, and 3. intraparenchymal LM only). The
registration accuracy was measured as fiducial registration error
(FRE).[50,51] Using surface LM resulted in an FRE of 3.5mm,
compared with 2.5mm for combined intraparenchymal and
surface LM registration and 2.2mm for intraparenchymal LM
registration (P= .052 and P= .035, respectively). The registration
process was faster using surface LM (01:51minutes) than
combined intraparenchymal and surface LM registration
(02:12minutes) or intraparenchymal LM registration alone
(02:58minutes). In a second experiment computer-assisted
image-guided resectionswere performed in a pancreatic phantom.
The resectionwasmade using a rigid endoscopewith amonopolar
loop. Six of 7 lesions that were invisible on the endoscopic view
were successfully targeted and completely resected onmacroscop-
ic evaluation of the pancreatic phantoms (Fig. 5).Given the limited
direct visibility and the complex anatomy of the pancreas, EPS
benefits of an image-guided navigation system (IG-NS) which was
feasible and useful in pancreaticmodels.[14] To date EPS has solely
been performed in pancreas phantoms and animal models. In our
opinion a first human study should be planned as a next step for a
thorough evaluation of EPS in highly selected clinical cases. As in
open pancreatic surgery, adequately placed drains around the
pancreas would be of paramount importance to manage potential
postoperative pancreatic fistula. If successful, EPS could poten-
tially fill the gap between current endoscopic and conventional
surgical treatments.
Image-guided endopancreatic interventions
Given the delicate anatomical structures surrounding the
pancreas, orientation and differentiation between benign and
malignant tissue remains difficult, especially when minimally
invasive techniques are used. As the minimization of the access in
Figure 3. Transduodenal endopancreatic resection with a rigid endoscope. (A) A duodenotomy is made opposite to the papilla. (B) The endoscope is advanced
over the papilla into the pancreatic duct. (C) Resection is performed from inside the duct.
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endopancreatic interventions prevents palpation and direct view
on the situs, more advanced imaging and guidance modalities are
required to identify, locate and treat diseased tissue. This led
researchers to investigate the applicability of image-guided
surgery systems to navigate surgical tools through the patient’s
body.[52]
While the liver has been considered extensively,[53–57] the use
of IG-NS in the pancreas has been sparse. However, the
bottleneck of minimally invasive IS-surgery is the intraoperative
organ deformation due to pneumoperitoneum and mobiliza-
tion.[58,59] Compared to the liver and other intraabdominal
organs,[60–62] the pancreas is potentially less susceptible to
intraoperative deformation due to its retroperitoneal location
and may therefore be a more suitable organ for IG-NS.
Initial attempts have used a projection of preoperatively
created 3D pancreas models onto the patient’s skin during
laparoscopic pancreas surgery (Fig. 6). However, the evaluated
system did not provide instrument navigation.[63] Stillström
et al[54] evaluated a navigation system designed for open liver
surgery during laparoscopic pancreas ablation. The system
provided means to register the real world with preoperative 3D
reconstructions of the pancreas and the surrounding anatomy to
navigate optically tracked instruments. The navigation informa-
tion was primarily used for the orientation of ablation needles in
relation to the tumor (Fig. 7).[54]
The main limitations of a clinical application of IG in
minimally invasive pancreatic surgery are large registration
errors that were already experienced during the application in
open surgery.[55,64,65] As already mentioned for EPS the CAS-
One navigation system is promising, as it showed successful
targeting of pancreatic lesions that indicates a sufficient
registration accuracy for navigation purposes.[14]
POP combined with IG would enable more precise diagnostic
procedures as the direct visualization is sometimes limited.
However, this approach requires a tracking modality that does
not suffer from the line-of-sight problem to track the endo-
scopes flexible tip. The use of electromagnetic tracking can be
seen as an alternative to conventional optical tracking and was
previously described in preclinical studies for laparoscopic
ultrasound-guided ablation of hepatic tumors.[66,67] It is likely
Figure 4. Experimental evaluation of endopancreatic surgery: (A) View of the pancreatic duct during endopancreatic surgery. (B) After resection, the pancreatic
duct was cut open to demonstrate the resection area. (C) Cut surface after the endopancreatic resection; the resection cavity was filled with blue polysiloxane. (D)
The resection cavity was cut open to demonstrate the extent of the resection from inside the pancreas.
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that with the improvement of IG surgery, not only the quality
of the diagnosis can be improved, but also the safety of the
intervention. In the future, a steep further technical progress
can be expected, that brings novel and improved concepts of
image guidance to endopancreatic interventions, making the
use of this access more accurate, more intuitive and therefore
safer.
Conclusion
The natural connection between the duodenum and the
pancreatic duct is already regularly used, mainly for diagnostic
and for certain therapeutic purposes. In animal models, the
endopancreatic access allows the direct visualization of the
pancreatic duct system potentially improving the diagnostic
work-up of pancreatic cystic neoplasms and intrapancreatic
strictures. Furthermore, the endopancreatic access could enable
interventions like the removal of pancreatic stones, intraductal
RFA and resection of pancreatic tissue from inside the pancreas.
Orientation and localization of target structures using this
minimally invasive approach is difficult therefore the develop-
ment of an accurate image guidance systemwill play a key role for
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